$4.00
-0.0299-0.74%
Last update: Nov 13, 9:19 AM
Oramed Pharmaceuticals Inc (ORMP) Stock Price, Quote, News & History
ORMPNASDAQ
Oramed Pharmaceuticals Inc (NASDAQ: ORMP) shares are trading higher after its partner completed Phase 3 trials of oral insulin in type 2 diabetes in China
You can purchase shares of Oramed Pharmaceuticals (NASDAQ:ORMP) through any online brokerage.
Other companies in Oramed Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
There is no analysis for Oramed Pharmaceuticals to provide a consensus price target.
The stock price for Oramed Pharmaceuticals (NASDAQ: ORMP) is $4.0001 last updated November 13, 2026 at 9:19 AM EST.
There are no upcoming dividends for Oramed Pharmaceuticals.
Oramed Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Oramed Pharmaceuticals.
Oramed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral...
